{"id":"W4414150792","doi":"10.1093/ecco-jcc/jjaf166","title":"Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID","year":2025,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Vedolizumab; Inflammatory bowel disease; Multicenter study; Ulcerative colitis; Crohn's disease; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003519157,0.0007803403,0.001007694,0.0003842007,0.0003149735,0.0009001691,0.0005005675,0.0005813075,0.001181528],"category_scores_gemma":[0.002423316,0.0004394873,0.001021938,0.0006434019,0.000492744,0.0005283625,0.0006106761,0.0006598743,0.0002371821],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005536075,"about_ca_system_score_gemma":0.000542315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008770779,"about_ca_topic_score_gemma":0.001177233,"domain_scores_codex":[0.9983435,0.001038582,0.0001307715,0.0001956724,0.0001531945,0.0001383477],"domain_scores_gemma":[0.9977209,0.0003871379,0.001106728,0.0002423806,0.0001397136,0.0004031027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.250192,0.005643877,0.6920793,0.0008052241,0.004472332,0.0002938524,0.0004669196,0.0004297531,0.00540079,0.000159819,0.001213925,0.03884225],"study_design_scores_gemma":[0.06140381,0.05011386,0.8811524,0.0001580009,0.002968716,0.0006514113,0.0002325921,0.000531991,0.0005059074,0.00006779942,0.002166867,0.00004669938],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966586,0.002296455,0.0001093718,0.00009896325,0.00001206364,0.0001611726,0.0002801052,0.000004989759,0.0003782528],"genre_scores_gemma":[0.9970329,0.0008073882,0.0005063787,0.000231998,0.0000929069,0.0002503897,0.0008735057,0.000005922044,0.0001985493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003519157,"threshold_uncertainty_score":0.01861131,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005139617083551681,"score_gpt":0.2308922702394382,"score_spread":0.2257526531558865,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}